By Josh White
Date: Wednesday 19 Jul 2023
(Sharecast News) - Predictive generics specialist GENinCode announced a collaboration with MedStar Health on Wednesday - a prominent 10-hospital health system in the Washington, DC area of the United States.
By Josh White
Date: Tuesday 03 Jan 2023
(Sharecast News) - Predictive genetics specialist GENinCode announced California state licensing approval and CLIA certification of its Irvine laboratory on Tuesday, enabling it to provide its products for the risk assessment of cardiovascular disease (CVD) to patients across 49 states in the US.
By Josh White
Date: Wednesday 23 Mar 2022
(Sharecast News) - Cardiovascular genetics company GENinCode announced a collaboration with the Indiana University School of Medicine (IU) on Wednesday - the largest medical school in the United States.
Currency | UK Pounds |
Share Price | 8.25p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 16.50 |
52 Week Low | 3.45 |
Volume | 37,838 |
Shares Issued | 176.96m |
Market Cap | £14.60m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:27 | 11,874 @ 8.39p |
11:09 | 227 @ 8.39p |
11:09 | 244 @ 7.83p |
10:18 | 25,000 @ 8.02p |
10:00 | 493 @ 8.01p |
CEO | Matthew Heaton Walls |
CFO | Paul Andrew Peter Foulger |
COO | Jordi Puig Gilberte |
You are here: research